Millions of people die as a direct result of bacterial infections — especially when the bacteria have developed a resistance to the antibiotics we use to treat them. It's this drug resistance that ...

Tuberculosis (TB) is the world's biggest infectious disease killer with multidrug-resistant TB (MDR-TB) posing a particular threat to global health. A study shows that resistance to the new MDR-TB ...

Women might be more likely to develop drug-resistant infections than men — an under-recognized aspect of the growing threat of antimicrobial resistance, according to a global review led by the World ...

Ōtākou Whakaihu Waka researchers have been part of two studies in the battle against drug resistant strains of Mycobacterium tuberculosis, the cause of tuberculosis. Co-author on both studies, Dr.

Scientists have discovered a new class of antibiotics with potent activity against multi-drug resistant bacteria, and have shown that it cures bloodstream infections in mice. Two publicly-funded ...

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, ...

Infection rates from “nightmare” drug-resistant bacteria have skyrocketed in the United States, scientists warned this week. Cases of patients infected with the gnarly bacteria rose an alarming 70% ...

Scientists at the University of Liverpool, working with international collaborators, have discovered Novltex, a groundbreaking new class of antibiotics with potent activity against some of the world's ...

At the Vrije Universiteit Brussel (VUB)—Flanders Institute for Biotechnology (VIB), biologist Jessie Vandierendonck has been investigating new, alternative treatments to combat bacterial infections ...